Nectar Lifescience Ltd

NSE: NECLIFE BSE: 532649

₹11.44

(1.63%)

Sat, 20 Jun 2026, 02:11 pm

MTF 5xInvest in Nectar Lifescience Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)223.4

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Nectar Lifescience News

Nectar Lifesciences Board Meeting

Nectar Lifesciences board meets on May 30, 2026 to consider FY26 audited results.

25 May 2026

companies

Nectar Lifesciences Wins Income Tax Assessment Case

Nectar Lifesciences Limited receives favorable order from Deputy Commissioner of Income Tax, Chandigarh, disposing of assessment matter for AY 2017-18 with no financial implications.

29 Apr 2026

companies

Nectar Lifesciences extends capsule business sale deadline

Nectar Lifesciences Ltd. has extended the completion date for the slump sale of its Empty Hard Gelatin Capsule business to July 31, 2026, under Regulation 30 of SEBI regulations.

28 Apr 2026

companies

Nectar Lifesciences Launches Saksham Niveshak Campaign

Nectar Lifesciences initiated its second 100-day 'Saksham Niveshak' shareholder outreach campaign from April 01, 2026 to July 09, 2026, aimed at helping investors update KYC details and claim unpaid dividends.

08 Apr 2026

companies

Nectar Lifesciences Files Q4 FY26 Demat Compliance

Nectar Lifesciences Limited submitted its quarterly dematerialization compliance certificate for Q4 FY26 to stock exchanges, confirming adherence to SEBI regulations through registrar KFin Technologies.

06 Apr 2026

companies

Showing 1–5 of 47

Rows per page:

Market Current News

Anubhav Plast IPO subscribed 1.2x

Anubhav Plast IPO subscribed 1.2x overall. QIB subscribed 1.01x, Retail 1.18x, and Non-Institutional Buyers saw strong demand.

19 Jun 2026

ipo

Jio Platforms to Offer 270 Million New Shares in IPO

Jio Platforms, a subsidiary of Reliance Industries, plans to offer 270 million new shares in an upcoming India IPO, marking a significant capital market development.

19 Jun 2026

ipo

QMS MEDICAL ALLIED S LTD

QMS Medical migrates to NSE Mainboard

QMS Medical Allied Services migrated 1.93 crore shares to NSE Mainboard. FY26 revenue stood at ₹172.9 crore with EBITDA of ₹25.9 crore.

18 Jun 2026

ipo

NSE files ₹30,000 crore DRHP

NSE filed a DRHP for a ₹30,000 crore Offer for Sale, set to be India's largest IPO. Shares will list on BSE.

18 Jun 2026

ipo

Dhanwel Hybrid Seeds IPO analysis

Dhanwel Hybrid Seeds IPO opens Jun 24, 2026, to raise ₹19.20 crore. Revenue grew 110% to ₹74.59 crore in FY26, but operating cash flows remain negative.

18 Jun 2026

ipo

Showing 1–5 of 93902

Rows per page: